Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
8.19
+0.15 (1.87%)
At close: Sep 30, 2026
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 18.28 billion as of October 2, 2026. Its market cap has decreased by -24.30% in one year.
Market Cap
18.28B
Enterprise Value
18.66B
Revenue
4.37B
Ranking
n/a
PE Ratio
31.57
Stock Price
8.19
ChartMarket Cap Chart
Since December 27, 2022, SHE:301301's market cap has decreased from 22.34B to 18.28B, a decrease of -18.16%. That is a compound annual growth rate of -5.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 18.28B | -19.15% |
| Dec 31, 2025 | 22.61B | -14.39% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
| Dec 27, 2022 | 22.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acrobiosystems | 20.56B |
| Xiamen Amoytop Biotech | 20.35B |
| Hebei Changshan Biochemical Pharmaceutical | 20.33B |
| Evopoint Biosciences | 18.99B |
| HitGen | 17.50B |
| Sino Biological,Inc. | 17.43B |
| Sinocelltech Group | 16.57B |
| BrightGene Bio-Medical Technology | 14.95B |